Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Monarin tablets

Dexa Medica

Ingredients in every tablet

Montelukast 10 mg

Each package contains

3 blisters of 10 tablets

Dosage form

tablet

Dosage formTablet; coated

Flavour

None

W.H.O. classification

R03D
R03D

A.T.C. Level 1

Anatomical Main group

R - Respiratory system
R03D

A.T.C. Level 2

Therapeutic subgroup

R03 - Drugs for Obstructive Airway Diseases
R03D

A.T.C. Level 3

Pharmacological subgroup

R03D - Other Systemic Drugs for Obstructive Airway Diseases in ATC

Available in

Indonesia

Warnings

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.

Pregnancy

CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

CAUTIONThis item may not be safe for use during lactation. Use with caution and after consultation with your doctor.

Indication

Monarin is indicated in adults for the prophylaxis and chronic treatment of asthma, including the prevention of exercise-induced bronchoconstriction.

Dosage

0 TO 15 YEARS OLD
Montelukast 10 mg tablets should not be prescribed.

15 YEARS OLD AND ABOVE
— Asthma
Monarin should be taken once daily in the evening (one-10 mg tablet)

— Exercise-Induced Bronchoconstriction (EIB)
For prevention of EIB, a single dose (one-10 mg tablet) of Monarin should be taken at least 2 hours before exercise.

An additional dose of Monarin should not be taken within 24 hours of a previous dose. Patients already taking Monarin daily for another indication (including chronic asthma) should not take an additional dose to prevent EIB. All patients should have available for rescue a short-acting β-agonist. Daily administration of Monarin for the chronic treatment of asthma has not been established to prevent acute episodes of EIB.

ADMINISTRATION
The therapeutic effect of montelukast on parameters of asthma control occurs within one day. Montelukast may be taken with or without food. Patients should be advised to continue taking montelukast even if their asthma is under control, as well as during periods of worsening asthma.

PATIENTS WITH RENAL IMPAIRMENT
No dosage adjustment is necessary for patients with renal insufficiency.

PATIENTS WITH MILD TO MODERATE HEPATIC IMPAIRMENT
No dosage adjustment is necessary for patients with mild to moderate hepatic impairment.